GPC3 and hepatocellular carcinoma: UPSND‐loaded with human sgRNA not only demonstrated effective in vivo gene editing in human HCC but also, when compared to monoclonal antibody drugs targeting GPC3, revealed that complete gene excision offers superior tumor suppression compared to mere physical blockade.